1000 | -0.4974 | 9.818 | -1.698 | 0.09049 | 0.9609 | -4.278 | 1000 | CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | ENSG00000170558 | 114020 |
10656 | -0.3083 | 9.04 | -1.741 | 0.08277 | 0.9609 | -4.25 | 10656 | KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 | ENSG00000131773 | 610421 |
10982 | -0.4067 | 7.391 | -1.776 | 0.07668 | 0.9609 | -4.225 | 10982 | MAPRE2 | microtubule-associated protein, RP/EB family, member 2 | ENSG00000166974 | 605789 |
1124 | -0.1667 | 4.05 | -1.64 | 0.102 | 0.9609 | -4.316 | 1124 | CHN2 | chimerin (chimaerin) 2 | ENSG00000106069 | 602857 |
1399 | -0.2968 | 9.256 | -1.917 | 0.05624 | 0.9609 | -4.124 | 1399 | CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | ENSG00000099942 | 602007 |
1859 | -0.1735 | 4.085 | -1.935 | 0.05389 | 0.9609 | -4.11 | 1859 | DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | ENSG00000157540 | 600855, 614014, 614104 |
1951 | -0.3128 | 4.683 | -2.43 | 0.0157 | 0.9609 | -3.691 | 1951 | CELSR3 | cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) | ENSG00000008300 | 604264 |
1998 | -0.2503 | 7.081 | -1.432 | 0.1531 | 0.9609 | -4.442 | 1998 | ELF2 | E74-like factor 2 (ets domain transcription factor) | ENSG00000109381 | NA |
2104 | 0.2894 | 4.252 | 2.607 | 0.009587 | 0.9609 | -3.519 | 2104 | ESRRG | estrogen-related receptor gamma | ENSG00000196482 | 602969 |
22936 | 0.1832 | 4.007 | 1.449 | 0.1485 | 0.9609 | -4.432 | 22936 | ELL2 | elongation factor, RNA polymerase II, 2 | ENSG00000118985 | 601874 |
22992 | -0.5393 | 8.092 | -2.563 | 0.01086 | 0.9609 | -3.562 | 22992 | KDM2A | lysine (K)-specific demethylase 2A | ENSG00000173120 | 605657 |
23172 | -0.2241 | 9.059 | -1.588 | 0.1133 | 0.9609 | -4.349 | 23172 | FAM175B | family with sequence similarity 175, member B | ENSG00000165660 | 611144 |
23317 | -0.29 | 7.971 | -1.486 | 0.1383 | 0.9609 | -4.411 | 23317 | DNAJC13 | DnaJ (Hsp40) homolog, subfamily C, member 13 | ENSG00000138246 | 614334 |
23321 | 0.4891 | 4.319 | 3.358 | 0.0008872 | 0.7834 | -2.669 | 23321 | TRIM2 | tripartite motif containing 2 | ENSG00000109654 | 614141 |
23390 | 0.3738 | 5.261 | 1.602 | 0.1102 | 0.9609 | -4.34 | 23390 | ZDHHC17 | zinc finger, DHHC-type containing 17 | ENSG00000186908 | 607799 |
23476 | -0.8454 | 9.431 | -3.357 | 0.0008902 | 0.7834 | -2.67 | 23476 | BRD4 | bromodomain containing 4 | ENSG00000141867 | 608749 |
24147 | -0.6619 | 8.12 | -1.941 | 0.05316 | 0.9609 | -4.105 | 24147 | FJX1 | four jointed box 1 (Drosophila) | ENSG00000179431 | 612206 |
2911 | -0.258 | 4.336 | -1.409 | 0.1599 | 0.9609 | -4.455 | 2911 | GRM1 | glutamate receptor, metabotropic 1 | ENSG00000152822 | 604473 |
3224 | -0.3648 | 5.449 | -1.476 | 0.1411 | 0.9609 | -4.417 | 3224 | HOXC8 | homeobox C8 | ENSG00000037965 | 142970 |
4076 | 0.6646 | 8.692 | 1.702 | 0.08977 | 0.9609 | -4.276 | 4076 | CAPRIN1 | cell cycle associated protein 1 | ENSG00000135387 | 601178 |
4204 | -0.4074 | 6.789 | -1.654 | 0.09913 | 0.9609 | -4.307 | 4204 | MECP2 | methyl CpG binding protein 2 (Rett syndrome) | ENSG00000169057 | 105830, 300005, 300055, 300260, 300496, 300673, 312750 |
4215 | -0.3197 | 7.869 | -1.509 | 0.1323 | 0.9609 | -4.397 | 4215 | MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | ENSG00000198909 | 602539 |
4651 | -0.3888 | 9.613 | -1.844 | 0.06623 | 0.9609 | -4.177 | 4651 | MYO10 | myosin X | ENSG00000145555 | 601481 |
473 | -0.2164 | 4.119 | -2.231 | 0.02645 | 0.9609 | -3.87 | 473 | RERE | arginine-glutamic acid dipeptide (RE) repeats | ENSG00000142599 | 605226 |
4857 | -0.2028 | 4.074 | -1.682 | 0.0936 | 0.9609 | -4.289 | 4857 | NOVA1 | neuro-oncological ventral antigen 1 | ENSG00000139910 | 602157 |
490 | -0.4168 | 7.764 | -1.805 | 0.07214 | 0.9609 | -4.205 | 490 | ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | ENSG00000070961 | 108731 |
51561 | 0.835 | 5.614 | 1.815 | 0.0705 | 0.9609 | -4.198 | 51561 | IL23A | interleukin 23, alpha subunit p19 | ENSG00000110944 | 605580 |
596 | -0.2569 | 4.863 | -1.404 | 0.1615 | 0.9609 | -4.458 | 596 | BCL2 | B-cell CLL/lymphoma 2 | ENSG00000171791 | 151430 |
6659 | 0.386 | 9.517 | 1.57 | 0.1174 | 0.9609 | -4.36 | 6659 | SOX4 | SRY (sex determining region Y)-box 4 | ENSG00000124766 | 184430 |
7430 | -0.2503 | 10.14 | -1.725 | 0.08557 | 0.9609 | -4.26 | 7430 | EZR | ezrin | ENSG00000092820 | 123900 |
79071 | -0.2258 | 4.783 | -1.638 | 0.1025 | 0.9609 | -4.317 | 79071 | ELOVL6 | ELOVL fatty acid elongase 6 | ENSG00000170522 | 611546 |
8165 | -0.2658 | 9.662 | -1.751 | 0.08103 | 0.9609 | -4.243 | 8165 | AKAP1 | A kinase (PRKA) anchor protein 1 | ENSG00000121057 | 602449 |
83439 | -0.474 | 6.188 | -2.107 | 0.03592 | 0.9609 | -3.974 | 83439 | TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | ENSG00000152284 | 604652 |
9568 | -0.7668 | 5.508 | -1.625 | 0.1053 | 0.9609 | -4.326 | 9568 | GABBR2 | gamma-aminobutyric acid (GABA) B receptor, 2 | ENSG00000136928 | 188890, 607340 |